Blog

News

Recent Posts

Validation of PCR oligos for SARS-CoV-2 test
The global SARS-CoV-2 pandemic is an emerging, rapidly evolving situation. Therefore, increasing the test capacity to detect a virus infection

Read more.

TubeLab facilitates laboratory routine
Waldsassen – BioVariance finishes the development of TubeLab, a software for the organisation of multi-level laboratory processes. To ensure an

Read more.

pressemitteilung-oncovariant
OncoVariant automates the drug search for oncologists
Waldsassen – BioVariance has finished the development of the platform “OncoVariant” for the interpretation of genetic variants in cancer patients.

Read more.

Colorectal cancer – The evil within
The facts „Colorectal carcinoma“ means several malignant tumor types in the colon or rectum. Malignant tumors rarely occur in other

Read more.

Off-Label Use in Paediatrics
The problem Generally, drugs are only allowed to be prescribed when special agencies have tested them on safety, effectiveness and

Read more.

Pressemitteilungen-press-releases
Optimization of colorectal cancer therapies by artificial intelligence
Waldsassen – BioVariance has received a commitment for the project “REVERT” from the European Commission as part of “HORIZON 2020”,

Read more.